Literature DB >> 24328856

The association between 25-hydroxyvitamin D and mammographic density in healthy pre- and postmenopausal women regardless of the menstrual cycle phase: a cross-sectional study.

Dae-Seong Heo1, Jeong-Gyu Lee, Hye-Rim Hwang, Sang-Yeoup Lee, Byung-Mann Cho, Sang-Soo Kim, Dong-Wook Jeong, Yu-Hyeon Yi, Young-Hye Cho, Yun-Jin Kim.   

Abstract

Vitamin D deficiency is a known risk factor of breast cancer. An association between vitamin D and breast density has been suggested; however, it remains controversial. The aim of this study was to determine the association between serum 25-hydroxyvitamin D [25(OH)D] level and mammographic density. Subjects in our study included 517 patients who visited the health promotion center of the University Hospital. Mammographic density was classified using the American College of Radiology, Breast Imaging Reporting and Data System. Analysis of variance was performed to clarify the association of serum 25(OH)D level and mammographic density, and odds ratio was calculated by ordinal logistic regression analysis. The mean serum 25(OH)D level was 14.3 ± 7.0 ng/mL in all subjects. In correlation analysis, weak negative correlation was observed between serum 25(OH)D level and mammographic density groups (r = -0.09, P = 0.049). However, ordinal logistic regression analysis showed no statistically significant association between serum 25(OH)D level and mammographic density (odds ratio: 0.75, 95% confidence interval: 0.50-1.13). Results of our study showed that there is no significant association between serum 25(OH)D level and mammographic density. It is thought to be an another mechanism of serum 25(OH)D level on breast cancer risk in addition to breast density.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24328856     DOI: 10.1080/01635581.2014.851715

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  6 in total

1.  Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.

Authors:  Kimberly A Bertrand; Bernard Rosner; A Heather Eliassen; Susan E Hankinson; Kathryn M Rexrode; Walter Willett; Rulla M Tamimi
Journal:  Breast Cancer Res Treat       Date:  2014-12-28       Impact factor: 4.872

2.  Increased vitamin D and calcium intake associated with reduced mammographic breast density among premenopausal women.

Authors:  Alecia Malin Fair; Toni J Lewis; Maureen Sanderson; William D Dupont; Sarah Fletcher; Kathleen M Egan; Anthony C Disher
Journal:  Nutr Res       Date:  2015-07-31       Impact factor: 3.315

3.  The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial.

Authors:  Marie E Wood; Heshan Liu; Elizabeth Storrick; David Zahrieh; H Carisa Le-Petross; Sin-Ho Jung; Patricia Zekan; M Margaret Kemeny; Jayne R Charlamb; Lili X Wang; Gary W Unzeitig; Candace S Johnson; Judy E Garber; James R Marshall; Isabelle Bedrosian
Journal:  Cancer Prev Res (Phila)       Date:  2021-04-13

4.  Association between 25-Hydroxy Vitamin D and volumetric breast density via a fully automated software Volpara™ in the reproductive age group.

Authors:  Bushra Wasim; Khalid Khan; Mohd Abdul Samad
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

5.  Clinical implications of vitamin D deficiency.

Authors:  Beata Matyjaszek-Matuszek; Monika Lenart-Lipińska; Ewa Woźniakowska
Journal:  Prz Menopauzalny       Date:  2015-06-22

6.  Serum 25-Hydroxyvitamin D3 and Mammography Density among Mexican Women.

Authors:  Amina Amadou; Carine Biessy; Sabina Rinaldi; Veronika Fedirko; Nada Assi; Martin Lajous; Eduardo Ortiz-Panozo; Elsa Yunes; Ruy Lopez-Ridaura; Gabriela Torres-Mejia; Isabelle Romieu
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.